P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma

• Eleonora Calabretta,
• Martina Di Trani,
• Martina Sollini,
• Francesca Ricci,
• Francesco Corrado,
• Vanessa Cristaldi,
• Stefanos Bonovas,
• Fabrizio Marino,
• Rita Mazza,
• Lodovico Terzi Di Bergamo,
• Alessio Bruscaggin,
• Maria Cristina Pirosa,
• Stefania Bramanti,
• Arturo Chiti,
• Armando Santoro,
• Davide Rossi,
• Carmelo Carlo-Stella

Affiliations

Eleonora Calabretta

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Martina Di Trani

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Martina Sollini

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Francesca Ricci

2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy

Francesco Corrado

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Vanessa Cristaldi

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Stefanos Bonovas

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Fabrizio Marino

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Rita Mazza

2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy

Lodovico Terzi Di Bergamo

4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland

Alessio Bruscaggin

4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland

Maria Cristina Pirosa

5 Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Stefania Bramanti

2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy

Arturo Chiti

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Armando Santoro

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy

Davide Rossi

4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland

Carmelo Carlo-Stella

1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy